Product Program year 2025 Source: CMS Open Payments

GammaTile

Device Cns

PDI 00860000064545

Open in the dashboard

General payments

$533,708

1,109 payments

Research payments

$1,942,646

1,102 payments

Through program year 2025, $533,708 in general payments and $1,942,646 in research payments were reported against GammaTile (Cns).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $533,708 1,109
2025 Research $1,942,646 1,102

Breakdown

Who paid General payments · program year 2025
  1. GT Medical Technologies, Inc $533,708 1,109 payments
Top recipients General payments · program year 2025
  1. David McCracken Neurological Surgery · Atlanta, GA $149,841 28% · 70 payments
  2. Joseph Zabramski Neurological Surgery · Phoenix, AZ $45,702 9% · 22 payments
  3. Imran Mohiuddin Radiation Oncology · Orlando, FL $37,885 7% · 28 payments
  4. Brandon Imber Radiation Oncology · New York, NY $24,159 5% · 20 payments
  5. Matthew Shepard Neurological Surgery · Pittsburgh, PA $22,417 4% · 15 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $301,894 57% · 192 practitioners
  2. Radiation Oncology Radiology $210,276 39% · 190 practitioners
  3. Hematology & Oncology Internal Medicine $9,417 2% · 12 practitioners
  4. Neurology Psychiatry & Neurology $3,184 <1% · 14 practitioners
  5. Internal Medicine $1,879 <1% · 9 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Georgia $150,447 28% · 3 recipients
  2. Arizona $67,276 13% · 15 recipients
  3. Florida $64,885 12% · 56 recipients
  4. California $49,852 9% · 34 recipients
  5. New York $43,913 8% · 17 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,109 general · 1,102 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record